Previous reports have highlighted the significant role of the TGF-β pathway in promoting angiogenesis and progression in breast cancer by inducing EndMT [62], thereby clarifying the promotive effect of the TGFB2-TGFBR2 on APOC1+ TAMs in tumor progression. This evidence concerns the gene TGFBR2 and breast carcinoma.